| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |